U.S. Drug Testing Market Size & Outlook, 2023-2030
U.S. drug testing market, 2018-2030 (US$M)
Related Markets
U.S. drug testing market highlights
- The U.S. drug testing market generated a revenue of USD 2,174.3 million in 2023 and is expected to reach USD 2,947.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.4% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Rapid Testing Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Drug testing market data book summary
| Market revenue in 2023 | USD 2,174.3 million |
| Market revenue in 2030 | USD 2,947.0 million |
| Growth rate | 4.4% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Rapid Testing Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Rapid Testing Devices, Services |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.5% of the global drug testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. drug testing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 361.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Testing Market Scope
Drug Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. drug testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 36.12% in 2023. Horizon Databook has segmented the U.S. drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
Alcohol consumption is one of the major factors expected to contribute to the U.S. drug testing market during the forecast period. According to a study published by The Pennsylvania State University, in 2021–2022, an estimated 63% of U.S. adults over 18 years and older consumed alcohol.
Furthermore, according to data published by the National Center for Drug Abuse Statistics (NCDAS) in February 2023, around 46% of the U.S. drug users have reported consumption of cannabis and prescription stimulants, which includes 10% of the population consuming cocaine, 36% using opioids & methamphetamine, and 15% heroin.
Reasons to subscribe to U.S. drug testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. drug testing market databook
-
Our clientele includes a mix of drug testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. drug testing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. drug testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. drug testing market size, by product, 2018-2030 (US$M)
U.S. Drug Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
